Deipanjan Nandi

Dr. Deipanjan Nandi

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2015 in Cardiology in the Young
Verified
Journal Article
Open access
PDF file
DNDeipanjan Nandi
Deipanjan Nandi
JRJoseph W. Rossano
Joseph W. Rossano
Heart failure in children is a complex disease process, which can occur secondary to a variety of aetiologies, including CHD, cardiomyopathy, or acquired conditions as well. Although the overall incidence of disease is low, the associated morbidity and mortality are high. Mortality may have decreased slightly over the last decade, and this is likely due to our ability to shepherd patients through longer periods of significant morbidity, with lasting effects. Costs of heart failure are significant – on the order of $1 billion annually as hospital charges for inpatient admissions alone. The value, or benefit to patient life and quality of life at this cost, is not well delineated. Further research is needed to optimise not only outcomes for these patients but also the high costs associated with them.

30 July 2024 in Circulation
Verified
Journal Article
Closed access
RBRyan J. Butts
Ryan J. Butts
LTLeah Toombs
Leah Toombs
JKJames K. Kirklin
James K. Kirklin
KSKurt R. Schumacher
Kurt R. Schumacher
JCJennifer Conway
Jennifer Conway
DPDavid M. Peng
David M. Peng
BACKGROUND: Waitlist mortality (WM) remains elevated in pediatric heart transplantation. Allocation policy is a potential tool to help improve WM. This study aims to identify patients at highest risk for WM to potentially inform future allocation policy changes. METHODS: The Pediatric Heart Transplant Society database was queried for patients 0.7 m 2 BSA groups. VAD support was associated with lower WM other than in the single ventricle cohort, where VAD was associated with higher WM. Extracorporeal membrane oxygenation and mechanical ventilation were associated with increased risk of WM in all cohorts. CONCLUSIONS: There is significant variability in WM among status-1A patients. Potential refinements to current allocation system should factor in the increased WM risk we identified in patients supported by extracorporeal membrane oxygenation or mechanical ventilation, single ventricle congenital heart disease on VAD support and small children with congenital heart disease, restrictive cardiomyopathy, or hypertrophic cardiomyopathy.

1 November 2018 in Pediatric Emergency Care
Verified
Journal Article
Closed access
PDF file
SMShaun Mohan
Shaun Mohan
DNDeipanjan Nandi
Deipanjan Nandi
PSPaul Stephens
Paul Stephens
MMMirna M'Farrej
Mirna M'Farrej
RVR. Lee Vogel
R. Lee Vogel
CBChristopher P. Bonafide
Christopher P. Bonafide
Objective: To evaluate the impact of a pediatric emergency department (ED) chest pain clinical pathway on resource utilization. Methods: Motivated by perceived overuse of cardiology consultation for non-cardiac chest pain in the ED, clinicians from the Divisions of Cardiology and Emergency Medicine collaboratively developed a chest pain clinical pathway, educated staff, and implemented the pathway on March 1, 2014. We reviewed records of children aged 3 to 18 years without prior diagnoses of heart disease who presented to the ED with chest pain between March 1, 2013, and April 22, 2015. We compared diagnostic testing rates, ED length of stay, and cardiology consults before and after implementation of the pathway. Results: A total of 1687 patients were pathway eligible (675 patients preimplementation and 1012 postimplementation). Resource utilization was lower than expected before pathway implementation and remained low after implementation. There was a statistically significant reduction in rates of chest x-ray ordering after pathway implementation and ED length of stay but no change in other diagnostic testing or cardiology consultation. Follow-up in our health care system for pediatric chest pain increased from 15% to 29% with implementation, but none of these visits resulted in the diagnosis of a new cardiac condition. There were no instances identified where use of the pathway resulted in missed cardiac disease. Conclusions: Implementation of a clinical pathway for pediatric chest pain did lead to a reduction in chest x-ray ordering in the ED and was associated with a higher rate of outpatient follow up for non-pathologic chest pain. Preimplementation utilization was lower than the prepathway perceptions of overuse suggested.

8 December 2015 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
DNDeipanjan Nandi
Deipanjan Nandi
KLKimberly Y. Lin
Kimberly Y. Lin
MOMatthew J. O’cOnnor
Matthew J. O’cOnnor
OEOkan U. Elci
Okan U. Elci
JKJeffrey J. Kim
Jeffrey J. Kim
JRJoseph W. Rossano
Joseph W. Rossano

1 January 2018 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
DNDeipanjan Nandi
Deipanjan Nandi
KMKelley D. Miller
Kelley D. Miller
CBCarley M. Bober
Carley M. Bober
TRTami M. Rosenthal
Tami M. Rosenthal
LMLisa M. Montenegro
Lisa M. Montenegro
CMChristopher E. Mascio
Christopher E. Mascio

1 November 2020 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
DNDeipanjan Nandi
Deipanjan Nandi
CCClifford Chin
Clifford Chin
KSKurt R. Schumacher
Kurt R. Schumacher
MFMatthew Fenton
Matthew Fenton
RSRakesh K. Singh
Rakesh K. Singh
EPElfriede Pahl
Elfriede Pahl